Hepatic embolotherapy in interventional oncology: Technology, techniques, and applications

Clinical Radiology

Volumn 68, Issue 1, 2013, Pages 1-15

  Kritzinger, J ^a   Klass, D ^a   Ho, S ^a   Lim, H ^a   Buczkowski, A ^a   Yoshida, E ^a   Liu, D ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; BEVACIZUMAB; BROMOPYRUVIC ACID; CISPLATIN; DOXORUBICIN; EMBOSPHERE; EMBOZENE; EPIRUBICIN; ETHIODIZED OIL; ETHIODOL ULTRA FLUIDE; GELATIN SPONGE; GELFOAM; IODINATED POPPYSEED OIL; IRINOTECAN; LIDOCAINE; LOBAPLATIN; MACROSALB TC 99M; MICROSPHERE; MITOMYCIN; OXALIPLATIN; PLATINUM DERIVATIVE; POLYMER; POLYVINYL ALCOHOL; POLYVINYL ALCOHOL SPONGE; RESIN; SOMATOMEDIN B; SORAFENIB; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; YTTRIUM 90;

ARTERY CATHETER; ARTIFICIAL EMBOLISM; BLAND EMBOLIZATION; CANCER RADIOTHERAPY; CHEMOEMBOLIZATION; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DRUG ELUTING BEAD; EMULSION; HEPATIC ARTERY; HUMAN; HYDROGEL; INTERVENTIONAL RADIOLOGY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; MATERIAL COATING; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; REVIEW; SELECTIVE INTERNAL RADIATION THERAPY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUSTAINED RELEASE PREPARATION;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CATHETERS; CHEMOEMBOLIZATION, THERAPEUTIC; EMULSIONS; EQUIPMENT DESIGN; ETHIODIZED OIL; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MICROSPHERES; NEOVASCULARIZATION, PATHOLOGIC; RADIOGRAPHY, INTERVENTIONAL; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 84871262535     PISSN: 00099260     EISSN: 1365229X     Source Type: Journal    
DOI: 10.1016/j.crad.2012.06.112     Document Type: Review

References (66)

1. J. Llovet, J. Fuster, and J. Bruix The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma Liver Transpl 10 2004 S115 S120
2. Benson, AB, Arnoletti JP, Bekaii-Saab T, et al. NCCN clinical practice guidelines in oncology: colon cancer; Version 2. 2012. Available at: http://www.nccn.org/professionals/physician-gls/f-guidelines.asp. [accessed 5.11.11].
3. Kulke MH, Clark OH, Benson AB, et al. NCCN Clinical Practice Guidelines in Oncology: Neuroendocrine Tumours; Version 1. 2011. Available at: http://www.nccn.org/professionals/physician-gls/f-guidelines.asp. [accessed 5.11.11].
4. J.M. Llovet, M.I. Real, and X. Montaña Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734 1739
5. R.J. Lewandowski, L.M. Kulik, and A. Riaz A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization Am J Transplant 9 2009 1920 1928
6. J. Lammer, K. Malagari, and T. Vogl Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study Cardiovasc Interv Radiol 33 2010 41 52
7. A. Hendlisz, M.V.D. Eynde, and M. Peeters Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy J Clin Oncol 28 2010 3687 3694
8. ® in patients with nonresectable liver tumors Cancer Biother Radiopharm 20 2005 200 208
9. R. Seidensticker, T. Denecke, and P. Kraus Matched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver-dominant colorectal metastases Cardiovasc Intervent Radiol 2011 Jul 29 10.1007/s00270-011-0234-7 [Epub ahead of print]
10. S. Kosmider, T.T. Tan, and D. Yip Radioembolization in combination with systemic chemotherapy as first-line therapy for liver metastases from colorectal cancer J Vasc Interv Radiol 22 2011 780 786
11. M. Cosimelli, R. Golfieri, and P.P. Cagol Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases Br J Cancer 103 2010 324 331
12. R.A. Sharma, G.A. Van Hazel, and B. Morgan Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy J Clin Oncol 25 2007 1099 1106
13. R. Kerbel Tumor angiogenesis N Engl J Med 358 2008 2039 2049
14. C. Breedis, and G. Young The blood supply of neoplasms in the liver Am J Pathol 30 1954 969 985
15. A. Kennedy, C. Nutting, and D. Coldwell Pathologic response and microdosimetry of 90Y microspheres in man: review of four explanted whole livers Int J Radiat Oncol Biol Phys 60 2004 1552 1563
16. W. Lien, and N. Ackerman The blood supply of experimental liver metastases. II. A microcirculatory study of the normal and tumor vessels of the liver with the use of perfused silicone rubber Surgery 68 1970 334 340
17. K.T. Sato, R.A. Omary, and C. Takehana The role of tumor vascularity in predicting survival after yttrium-90 radioembolization for liver metastases J Vasc Interv Radiol 20 2009 1564 1569
18. R. Loffroy, B. Guiu, and J. Cercueil Endovascular therapeutic embolisation: an overview of occluding agents and their effects on embolised tissues Curr Vasc Pharmacol 7 2009 250 263
19. K.T. Brown, A.B. Nevins, and G.I. Getrajdman Particle embolization for hepatocellular carcinoma J Vasc Interv Radiol 9 1998 822 828
20. E. Liapi, and J.F. Geschwind Research and future directions in oncology embolotherapy J. Golzarian, Vascular embolotherapy 1st ed. 2006 Springer-Verlag Berlin 221 232
21. A. Laurent, M. Wassef, and J.P. Saint Maurice Arterial distribution of calibrated tris-acryl gelatin and polyvinyl alcohol microspheres in a sheep kidney model Invest Radiol 41 2006 8 14
22. K.T. Brown Fatal pulmonary complications after arterial embolization with 40-120-μm tris-acryl gelatin microspheres J Vasc Interv Radiol 15 2004 197 200
23. H. Ahmadzadehfar, A. Sabet, and K. Biermann The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment J Nucl Med 51 2010 1206 1212
24. Z.-P. Xiong, S.-R. Yang, and Z.-Y. Liang Association between vascular endothelial growth factor and metastasis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma Hepatobiliary Pancreat Dis Int 3 2004 386 390
25. B.C. Song, Y.H. Chung, and J.A. Kim Association between insulin-like growth factor-2 and metastases after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: a prospective study Cancer 91 2001 2386 2393
26. M.-W. Welker, and J. Trojan Anti-angiogenesis in hepatocellular carcinoma treatment: current evidence and future perspectives World J Gastroenterol 17 2011 3075 3081
27. M.A. Maluccio, A.M. Covey, and L.B. Porat Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma J Vasc Interv Radiol 19 2008 862 869
28. T. Konno, H. Maeda, and K. Iwai Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report Eur J Cancer Clin Oncol 19 1983 1053 1065
29. H. Nakamura, T. Hashimoto, and H. Oi Transcatheter oily chemoembolization of hepatocellular carcinoma Radiology 170 1989 783 786
30. K. Hong, H. Kobeiter, and C.S. Georgiades Effects of the type of embolization particles on carboplatin concentration in liver tumors after transcatheter arterial chemoembolization in a rabbit model of liver cancer J Vasc Interv Radiol 16 2005 1711 1717
31. K.-H. Lee, E. Liapi, and V.P. Ventura Evaluation of different calibrated spherical polyvinyl alcohol microspheres in transcatheter arterial chemoembolization: VX2 tumor model in rabbit liver J Vasc Interv Radiol 19 2008 1065 1069
32. M.M. Gottesman Mechanisms of cancer drug resistance Annu Rev Med 53 2002 615 627
33. J. Bruix, M. Sala, and J.M. Llovet Chemoembolization for hepatocellular carcinoma Gastroenterology 127 2004 S179 S188
34. R.C.G. Martin, J. Joshi, and K. Robbins Transarterial chemoembolization of metastatic colorectal carcinoma with drug-eluting beads, irinotecan (DEBIRI): multi-institutional registry J Oncol 2009 2009 539795 Epub 2009 Oct 29
35. M. Vali, E. Liapi, and J. Kowalski Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer J Vasc Interv Radiol 18 2007 95 101
36. Z. Kan, K. Wright, and S. Wallace Ethiodized oil emulsions in hepatic microcirculation: in vivo microscopy in animal models Acad Radiol 4 1997 275 282
37. P. Johnson, C. Kalayci, and N. Dobbs Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of Lipiodol J Hepatol 13 1991 120 127
38. K. Hong, A. Khwaja, and E. Liapi New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer Clin Cancer Res 12 2006 2563 2567
39. R. Murthy, R. Nunez, and J. Szklaruk Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications RadioGraphics 25 Suppl. 1 2005 S41 S55
40. D.M. Liu, R. Salem, and J.T. Bui Angiographic considerations in patients undergoing liver-directed therapy J Vasc Interv Radiol 16 2005 911 935
41. A. Tognolini, J. Louie, and G. Hwang C-arm computed tomography for hepatic interventions: a practical guide J Vasc Interv Radiol 21 2010 1817 1823
42. L. Marelli, R. Stigliano, and C. Triantos Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies Cardiovasc Intervent Radiol 30 2007 6 25
43. L. Tessari, A. Cavezzi, and A. Frullini Preliminary experience with a new sclerosing foam in the treatment of varicose veins Dermatol Surg 27 2001 58 60
44. G.G. Hartnell, J. Gates, and K. Stuart Hepatic chemoembolization: effect of intraarterial lidocaine on pain and postprocedure recovery Cardiovasc Intervent Radiol 22 1999 293 297
45. O. Jordan, A. Denys, and T. De Baere Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC Bead and hepasphere loaded with doxorubicin and irinotecan J Vasc Interv Radiol 21 2010 1084 1090
46. D.M. Liu, S. Kos, and A. Buczkowski Optimization of doxorubicin loading for superabsorbent polymer microspheres: in vitro analysis Cardiovasc Intervent Radiol 35 2012 391 398
47. S. Kos, E. Wasan, and G. Weir Elution characteristics of doxorubicin-loaded microspheres differ by drug-loading method and microsphere size J Vasc Interv Radiol 22 2011 361 368
48. A.L. Lewis, R.R. Taylor, and B. Hall Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization J Vasc Interv Radiol 17 2006 1335 1343
49. K. Malagari, E. Alexopoulou, and K. Chatzimichail Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead Abdom Imaging 33 2008 512 519
50. H. Van Malenstein, G. Maleux, and V. Vandecaveye A randomized phase II study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinoma Onkologie 34 2011 368 376
51. S. Gupta, K.C. Wright, and J. Ensor Hepatic arterial embolization with doxorubicin-loaded superabsorbent polymer microspheres in a rabbit liver tumor model Cardiovasc Intervent Radiol 34 2011 1021 1030
52. D. Klass, D. Owen, and M.M. Slattery Embolic load and dose of doxorubicin in the treatment of hepatocellular carcinoma utilizing drug-eluting superabsorbent polymer microspheres: phase II trial of radiological/ histopathological correlation of treatment and response J Vasc Interv Radiol 22 Suppl. 2011 S75 Abstract no. 173
53. O'Connell TW, Slattery MM, Klass D, et al. Incidence and characterization of adverse reactions relating to outpatient-based doxorubicin/superabsorbant polymer microsphere embolization in hepatocellular carcinoma: dose escalation study. Cardiovascular and Interventional Radiological Society of Europe 2011; Poster Presentation.
54. M. Grosso, C. Vignali, and P. Quaretti Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study Cardiovasc Intervent Radiol 31 2008 1141 1149
55. R. Salem, and K.G. Thurston Radioembolization with 90-yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies, part 1: technical and methodologic considerations J Vasc Interv Radiol 17 2006 1251 1278
56. R. Salem, and K.G. Thurston Radioembolization with 90-yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies, part 2: special topics J Vasc Interv Radiol 17 2006 1425 1439
57. A. Kennedy, S. Nag, and R. Salem Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium Int J Radiat Oncol Biol Phys 68 2007 13 23
58. A. Riaz, V.L. Gates, and B. Atassi Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization Int J Radiat Oncol Biol Phys 79 2011 163 171
59. D.A. Leung, J.E. Goin, and C. Sickles Determinants of postembolization syndrome after hepatic chemoembolization J Vasc Interv Radiol 12 2001 321 326
60. J.E. Goin, R. Salem, and B.I. Carr Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities J Vasc Interv Radiol 16 2005 205 213
61. ®) Psychooncology 13 2004 73 79
62. B. Atassi, A.K. Bangash, and R.J. Lewandowski Biliary sequelae following radioembolization with yttrium-90 microspheres J Vasc Interv Radiol 19 2008 691 697
63. 18F] fluorodeoxyglucose positron emission tomography and computed tomographic imaging J Vasc Interv Radiol 16 2005 1641 1651
64. T. Szyszko, A. Al-Nahhas, and P. Tait Management and prevention of adverse effects related to treatment of liver tumours with 90Y microspheres Nucl Med Commun 28 2007 21 24
65. R. Salem, P. Parikh, and B. Atassi Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution Am J Clin Oncol 31 2008 431 438
66. R. Murthy, D. Brown, and R. Salem Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy J Vasc Interv Radiol 18 2007 553 561